CYTOVIA THERAPEUTICS
Cytovia Therapeutics develops transformational cancer immunotherapies and addresses several unmet medical needs for cancer prevention. The company was founded in 2022 by Daniel Teper and is headquartered in Aventura, Florida.
CYTOVIA THERAPEUTICS
Industry:
Alternative Medicine Biotechnology Health Care Medical
Founded:
2022-01-01
Address:
Aventura, Florida, United States
Country:
United States
Website Url:
http://www.cytoviatx.com
Total Employee:
11+
Status:
Active
Contact:
786-591-7001
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail YouTube
Similar Organizations
ACM Biolabs
ACM Biolabs develops novel vaccines and antibodies using proprietary artificial cell membrane technology.
BCISim
BCISim, Inc. has developed a new technology that addresses the unmet medical need of neurological disorders.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Sextant Therapeutics
Sextant is developing personalized cancer therapies that trigger the tumor to recruit the patient's own cancer-killing immune response.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-07 | Cytovia Therapeutics Appoints Luca Scavo as Chief Financial Officer and James Priour as Chief Product Officer |
Official Site Inspections
http://www.cytoviatx.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Cytovia Therapeutics"
About - Cytovia Therapeutics
About Cytovia Therapeutics - Cytovia is dedicated to the development of transformational cancer immunotherapies, addressing several of the most challenging unmet medical needs including the prevention of cancer relapse …See details»
Leadership - Cytovia Therapeutics
Head of New Product Development & Research Alliances. Armin Rath, PhD. Cytovia TherapeuticsSee details»
Cytovia Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 786-591-7001 Cytovia Therapeutics develops transformational cancer immunotherapies and addresses several unmet medical needs for cancer prevention.See details»
Cytovia Therapeutics - LinkedIn
Cytovia Therapeutics aims to accelerate patient access to transformational cell therapies and immunotherapies, addressing several of the most challenging unmet medical needs in cancer.See details»
CYTOVIA Therapeutics and the New York Stem Cell Foundation …
Jan 9, 2020 Research teams will use stem cell and gene editing technologies to advance NK cell-based therapies for cancer. New York, New York (January 9, 2020) – The New York Stem …See details»
Cytovia Therapeutics - BIO Investor Forum | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... (NYSCF), National Cancer …See details»
Recommended Stories
Sep 13, 2021 Cytovia eligible for up to $400 million in licensing milestones for Greater China rightsCoordinated US and China clinical development of GPC3-targeted therapies for …See details»
Cytovia Therapeutics Expands Leadership Team - Yahoo Finance
May 13, 2021 Jason Aryeh elected to Board of DirectorsElizabeth Schwarzbach, PhD and Boris Reznik, PhD join Strategic Advisory BoardElysa Mantel appointed as Vice President, General …See details»
Cytovia Therapeutics and its Newly Formed China-Focused
Sep 13, 2021 www.cytoviatx.com. About TF Capital TF Capital focuses on investment in the life sciences industry, primarily investing in early stage companies with high potential. Through …See details»
Cytovia Therapeutics announces plans to initiate in 2021 Clinical ...
Dec 8, 2020 The company partners with the University of California San Francisco (UCSF), the New York Stem Cell Foundation (NYSCF), the Hebrew University of Jerusalem, INSERM, and …See details»
Partnerships - Cytovia Therapeutics
Cytovia has been built through multiple collaborations with academic researchers, leading medical centers, and strategic partners. We aim to accelerate the transformation of cancer therapy and …See details»
Targeting oncology with two NK cell platforms - Nature
Www.cytoviatx.com Targeting oncology with two NK cell platforms With its plug-and-play cell therapy platform and complementary bispecific NK cell engagers, Cytovia aims to create both …See details»
Cytovia Therapeutics and NYSCF Announce Filing of Provisional …
Aug 25, 2020 Learn more at www.cytoviatx.comFor more information please contact:Cytovia TherapeuticsNYSCF Research Institute Sophie BadréDavid McKeon Vice President, …See details»
CytoLynx Therapeutics | Cytovia Therapeutics
CytoLynx Therapeutics is a Shanghai-based biotechnology company, created by a syndicate of institutional investors led by TF Capital and Yunfeng Capital.See details»
Cytovia and Cellectis Expand Their TALEN® Gene-Edited iNK …
Nov 18, 2021 [email protected] +1 (929) 317-1565. Shani Lewis LaVoieHealthScience [email protected] +1 (609) 516-5761. Forward-looking …See details»
Cytovia and Cellectis Expand Their TALEN® Gene-Edited iNK …
Nov 18, 2021 Find out more at www.cytoviatx.com. About Cellectis. Cellectis is a gene editing company, developing first of its kind therapeutic products. Cellectis utilizes an allogeneic …See details»
Our Technology - Cytovia Therapeutics
Your immune system's first and best line of defense against cancer and virally infected cells. Powerful. Precise. Innate. (And on your side so don't let the name scare you.)See details»
Media - Cytovia Therapeutics
Find out more at www.cytoviatx.com. 0:00 Introduction 1:02 Induced Pluripotent Stem Cells 1:50 Gene Editing 2:43 Chimeric Antigen Receptors (CARs) 3:06 Creating a Uniform Master Cell …See details»
Cytovia and Cellectis Expand Their TALEN® Gene-Edited iNK
Nov 18, 2021 [email protected] +1 (929) 317-1565. Shani Lewis LaVoieHealthScience [email protected] +1 (609) 516-5761. Forward-looking …See details»